Market veteran Ambareesh Baliga suggests pharmaceutical stocks offer a safe haven amidst currency volatility and cautious foreign investor sentiment. He advises focusing on top-tier pharma companies. Baliga also expresses caution on jewellery stocks due to increased gold import duties and anticipates margin pressures, while maintaining a positive outlook on Tata Motors and a bullish long-term view on Solar Industries India.
Amber Enterprises shares crash 18% after Q4 results. What’s spooking investors?
Amber Enterprises shares plunged almost 18% on Monday. This followed the company’s January-March quarter results. Net profit rose 15% year-on-year to Rs 134 crore. Revenue